MARKET

ABBV

ABBV

Abbvie Inc
NYSE
171.56
-2.14
-1.23%
After Hours: 171.85 +0.29 +0.17% 19:40 01/17 EST
OPEN
172.88
PREV CLOSE
173.70
HIGH
173.99
LOW
171.27
VOLUME
7.85M
TURNOVER
--
52 WEEK HIGH
205.38
52 WEEK LOW
149.57
MARKET CAP
303.17B
P/E (TTM)
59.85
1D
5D
1M
3M
1Y
5Y
1D
Count on Dividend King Pepsi ($PEP) for Stability in a Volatile Market
TipRanks · 9h ago
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
TipRanks · 10h ago
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Benzinga · 11h ago
3 Recession-Proof Dividend Stocks To Buy Today
Barchart · 13h ago
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Benzinga · 14h ago
Pharma lobby slams IRA, PBMs as Medicare lists 15 more drugs for price setting
Seeking Alpha · 14h ago
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales
Barchart · 16h ago
'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Benzinga · 17h ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It researches and develops, manufactures, commercializes and sells medicines and therapies. Its product portfolio includes immunology, oncology, aesthetics, neuroscience, eye care and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology. Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia and Diffuse large B-cell lymphoma. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders and Alzheimer’s disease. Eye Care includes Chronic Dry Eye Disease, Glaucoma, Age-Related Retinal Diseases, and Refractive Disorders. Aesthetics includes Botox Cosmetic, The Juvederm Collection of Fillers and others. Its NX-13 for the treatment of ulcerative colitis and Crohn's disease. Its CEL383 for the treatment of inflammatory bowel disease. Its ALIA-1758 for the treatment of patients with Alzheimer's disease.

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.